< Back to Results

Primary Contact Name
Trisha Sanchez
Primary Contact Email Address
Trisha.Sanchez@hci.utah.edu
Primary Contact Phone Number
8015850120
Program Name
HEMATOPOIETIC PROGENITOR CELL TRANSPLANTATION (HPCT) AND CELLULAR THERAPY FELLOWSHIP
Address
Huntsman Cancer Institute
2000 Circle of Hope Dr.
Salt Lake City, UT, 84112
Website
https://medicine.utah.edu/internal-medicine/hematology/fellowship/hpct
Program Director/Fellowship Director
Daniel Couriel
Program Director/Fellowship Director Email
daniel.couriel@hsc.utah.edu
Is the primary focus of your program on Blood and Marrow Transplantation (BMT) or Cellular Therapies?
BTH
How long is the Fellowship program at your institution?
One Year
How long is the BMT Fellowship program at your institution?
Not Provided
Option to extend training or research if funding is available?
Yes
Is the primary focus of your program on adult or pediatric populations?
Adult
How long before the Fellowship start date should applicants apply?
7-12 Months
When does your Fellowship application period begin?
January
When does your Fellowship application period end?
December
Interview required?
Yes
Interview Format
Virtual
How many training spaces?
Two
If you selected other, how many training spaces are there?
Not Provided
When does your program typically start?
July
If flexible, please describe
Not Provided
Visa Sponsorship?
Yes
If you selected yes, please specify the type of visa
J1
What are the requirements for fellows applying to your program?
Completion of residency training (Board Certified) or equivalent abroad, Completion of Hematology and/or Oncology Fellowship or equivalent (Board Eligible), ECFMG certification if IMG applicant, Eligibility to obtain a State Medical License
If you selected other, please explain
Not Provided
Are there any unique training opportunities in your fellowship program? (For example: rotation with CTRM, H&I Lab, exposure to CAR T Therapy, etc.)
The Utah Fellowship in HPCT and Cellular Therapy includes all essential clinical, operational, technical, regulatory and quality aspects of HPCT and cellular therapy, including elements of regenerative medicine. Throughout the year, fellows will be expected to participate in clinical rotations and didactic activities to fulfill the educational objectives shown below. Additionally, fellows are expected to design one clinical research project that might lead to extension of the fellowship to an additional year as needed for its completion. , Educational Objectives: , • Develop a sound understanding of the pathophysiological principles underlying HPCT, including those of hematopoiesis and immunology. , • Become competent in the care of adult patients with hematologic malignant and nonmalignant disorders undergoing HPCT. , • Achieve competency in procedural and technical skills required for the evaluation and care of HPCT patients. , • Develop proficiency and hands-on experience in apheresis and cell processing applied to HPCT. , • Acquire in-depth knowledge of clinical operations, quality and regulatory aspects of HPCT, including apheresis and cell processing. , • Develop the necessary skills to design and conduct clinical trials in HPCT and cellular therapy.
Continuity Clinic with trainee as primary physician with supervision?
Yes
Approximate volume of cases at your center for the following
Autologous Transplant
100
Allogeneic Transplant
50
CAR T
50
Approximate Structure (In weeks)
Inpatient
10
Outpatient/Consults
2
Research
24
Lab-Based
7
Other (specify)
QA/Database/Transplant Coordination- 1, CTO/Regulatory- 1, Flow Cytometry- 2
Sample Schedule Upload
Educational Stipend/Conference funding available:
No
Specify the Educational Stipend/Conference funding available
Not Provided
If you were interested in the standard time frame, what part of the process would you be interested in standardizing?
Start Date

< Back to Results